Repono IPO allotment to be out soon: Here are steps to check status online and GMP as focus shifts to listing
Since the Repono IPO is to be listed on BSE SME, with a tentative listing date of Monday, August 4, 2025, and Cameo Corporate Services Limited is the registrar for the issue, investors can check the allotment status on the BSE site or the registrar Cameo Corporate Services Limited site.
Here are steps to check status online and GMP as focus shifts to listing.
Step 1: Go to the website of Registrar Cameo Corporate Services Limited to check the Repono IPO allotment status by clicking the link:
Step 2- Click on any one of the links.
Step 3: Select Repono from the 'Select company name' dropdown menu. (Note: the company name will only appear once the allotment status is out.)
Step 3: Select from the selection type any of the following: the application number, the PAN number, or the DP number.
Step 4: Enter the details from the option selected on the Value Box
Step 5: Click the SUBMIT button after entering the captcha.
Step 1: Head to the BSE website:
Step 2: Select Issue type and click on Equity
Step 3: Under the select issue name, select "REPONO LIMITED" from the dropdown
Step 4: Thereafter, enter your details, such as application number and PAN information.
Step 5: Press 'Submit' after clicking the CAPTCHA
On July 31, Repono IPO GMP, or the Grey Market Premium, stood at +23. This means that Repono shares are selling in the grey market at an ₹ 23 premium over the issue price's upper range of ₹ 96.
Investors anticipate Repono shares to be listed at a premium of 23.96%, or ₹ 23, above the upper range of the offering price of ₹ 119.
Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 minutes ago
- The Hindu
Sensex drops 308 points ahead of RBI policy decision; RIL, HDFC Bank major drags
Benchmark stock indices Sensex and Nifty closed lower on Tuesday (August 5, 2025) following selling in oil, gas and banking shares ahead of the Reserve Bank's monetary policy announcement on August 6. The 30-share BSE Sensex fell by 308.47 points or 0.38% to close at 80,710.25. During the day, it declined 464.32 points or 0.57% to hit an intraday low of 80,554.40. The broader NSE Nifty fell 73.20 points or 0.30% to close at 24,649.55. In the intraday session, it slipped by 132.45 points or 0.53% to 24,590.30. Among Sensex shares, Adani Ports, Reliance Industries, Infosys, ICICI Bank, Eternal, BEL, HDFC Bank, Power Grid, ITC and Sun Pharmaceutical were the major laggards. However, Titan, Maruti, Trent, Bharti Airtel, Bajaj Finance, Tech Mahindra, State Bank of India, L&T, HCL Technologies and NTPC were among the gainers. The BSE smallcap gauge went lower by 0.27% and the midcap index by 0.14%. In Asian markets, South Korea's Kospi, Shanghai's SSE Composite index, Hong Kong's Hang Seng and Japan's Nikkei 225 index closed in the positive territory. The European markets were trading in green. The U.S. markets ended higher on Monday. Global oil benchmark Brent crude declined 1.02% to $68.06 a barrel. Foreign Institutional Investors offloaded equities worth ₹2,566.51 crore while Domestic Institutional Investors purchased equities worth ₹4,386.29 crore on Monday, according to exchange data. On Monday, the 30-share Sensex gained 418.81 points to settle at 81,018.72, and the NSE Nifty jumped by 157.40 points to close at 24,722.75.
Mint
2 minutes ago
- Mint
Penny stock hits upper circuit despite selling pressure in Indian stock market; here's why
Penny stock Welcure Drugs & Pharmaceuticals hit the 5% upper circuit on Tuesday, August 5, defying the weakness in the Indian stock market, bolstered by the stellar Q1 results for the financial year 2025-26 (FY26). The penny stock hit the day's high of ₹ 10.11 apiece in intraday deals today, also its 5% upper price band. The stock settled at this level. For the quarter ended June 2025, Welcure Drugs & Pharmaceuticals posted a sharp surge in both revenue and profits on a quarter-on-quarter (QoQ) basis, driving the penny stock higher. Welcure Drugs & Pharmaceuticals' revenue from operations stood at ₹ 299.91 crore in Q1FY26, up from ₹ 21.21 crore previous quarter (Q4FY25), making it about a 1300% rise on a QoQ basis. Meanwhile, its net profit came in at ₹ 23.29 crore during the quarter under review, marking a growth of nearly 830% QoQ as against ₹ 2.5 crore registered in Q4FY25. Speaking on the solid financial performance in Q1FY26, the management of the company commented, 'The strong financial performance in Q1FY26, is a reflection of our business strategies, meticulous decisions and our focused transition to a fee-based, asset-light model. We are committed to sustaining this performance through efficient supply chain management and product diversification.' The company implemented important leadership decisions to streamline governance for robust growth, it said. It has appointed Rabi Thakor as an Additional Non-Executive Non-Independent Director. The company also appointed Yogeshkumar Prajapati and Bhumika Pradhan as Additional Independent Directors. While the penny stock Welcure Drugs & Pharmaceuticals has seen a volatile performance in the near term, it has emerged as a multibagger on a long-term basis. According to BSE data, Welcure Drugs & Pharmaceuticals' share price has risen 38% in the last one year, but lost 9% on a year-to-date basis. While the stock is down 18% in a month, its three-month gains amount to 14%, reflecting sharp volatility. However, over a two-year period, the penny stock has added 164% and on a five-year basis, it has surged 660%. Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
2 minutes ago
- Mint
Brewery stock rebounds as board sets meeting to declare dividend record date, Q1 results 2025
BCL Industries share price saw a recovery during Tuesday's trading session and closed above the day's low after the company announced that its Board of Directors meeting will take place on August 12, 2025. According to the filing, the board will review and approve the unaudited financial results, both standalone and consolidated, for the quarter ending June 30, 2025. The agenda will also include discussions about relocating the company's registered office within the municipal limits of Bathinda city. Additionally, the Board will discuss setting the date and time for the 49th Annual General Meeting of the company, along with other relevant issues. The meeting will also establish the record date for declaring dividends for the financial year 2024–25. Importantly, during the presentation of its Q4 results in May, BCL Industries' board announced a dividend of 26 percent on each Re 1 share for the relevant period. This 26 percent dividend equates to a payout of Re 0.26. "Recommended an equity dividend of 26 paisa per share on face value of Re 1 each, i.e. for the financial year ended March 31, 2025, which shall be subject to declaration by the Members at the 49th AGM of the Company," said BCL Industries in a filing then. BCL Industries share price today closed at ₹ 44.30 apiece on the BSE, the stock touched an intraday high at ₹ 44.89 per share, and an intraday low of ₹ 43.95 apiece. According to Anshul Jain, Head of Research at Lakshmishree Investments, BLC Industries share price is currently trading in a broad range of 50–35, with some early signs of institutional accumulation. However, the overall price action lacks strong bullish confirmation, indicating that the base is still under development. 'The stock appears to need more time to consolidate and build a stronger foundation before any sustainable upmove. A decisive breakout above 50, supported by rising volumes, will be the key trigger to confirm strength. Once that level is breached, the stock has the potential to move toward the 60 mark in the short to medium term,' said Jain. Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.
